These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12143062)

  • 1. Good news for hepatorenal syndrome.
    Ginès P; Guevara M
    Hepatology; 2002 Aug; 36(2):504-6. PubMed ID: 12143062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progression on the use of vasoactive agents in the treatment of hepatorenal syndrome].
    Zheng YY; Xu XY
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):718-20. PubMed ID: 22152395
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged infusion of ornithine plus dopamine in the treatment of the hepatorenal syndrome: a breakthrough?
    Conn HO
    Am J Gastroenterol; 2000 Dec; 95(12):3645-6. PubMed ID: 11151911
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatorenal syndrome: pathophysiology and management.
    Wadei HM; Mai ML; Ahsan N; Gonwa TA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1066-79. PubMed ID: 17699328
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatorenal syndrome--pathogenesis and clinical aspects].
    Saracyn M
    Pol Arch Med Wewn; 2001 Nov; 106(5):1087-92. PubMed ID: 12026524
    [No Abstract]   [Full Text] [Related]  

  • 7. Terlipressin. Type I hepatorenal syndrome: an extra window of time before liver transplantation.
    Prescrire Int; 2006 Dec; 15(86):220. PubMed ID: 17171813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?
    Duhamel C; Mauillon J; Berkelmans I; Bourienne A; Tranvouez JL
    Am J Gastroenterol; 2000 Oct; 95(10):2984-5. PubMed ID: 11051385
    [No Abstract]   [Full Text] [Related]  

  • 9. The growing evidence that renal function should be improved in patients with cirrhosis and hepatorenal syndrome before liver transplantation.
    Moreau R
    J Hepatol; 2004 Jan; 40(1):159-61. PubMed ID: 14672628
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2005 May; 40(5):491-500. PubMed ID: 16036500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatorenal syndrome.
    Munoz SJ
    Med Clin North Am; 2008 Jul; 92(4):813-37, viii-ix. PubMed ID: 18570944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of hepatorenal syndrome.
    McCormick P; O'Keefe C; Docherty J
    Ir Med J; 1999; 92(7):422, 424. PubMed ID: 10967862
    [No Abstract]   [Full Text] [Related]  

  • 13. The management of hepatorenal syndrome.
    Carl DE; Sanyal A
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatorenal syndrome: a new therapeutic approach?].
    Gerbes AL; Gülberg V
    Z Gastroenterol; 1999 Sep; 37(9):983-5. PubMed ID: 10522370
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging role of vasopressin.
    Daga MK; Singh KJ; Kumar N
    J Assoc Physicians India; 2006 May; 54():376-80. PubMed ID: 16909734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is type 2 hepatorenal syndrome still a potential indication for treatment with terlipressin and albumin?
    Angeli P; Piano S
    Liver Transpl; 2015 Nov; 21(11):1335-7. PubMed ID: 26369385
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy for hepatorenal syndrome].
    Liu P
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):627. PubMed ID: 14572348
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current treatments for hepatorenal syndrome].
    Liu S; He WX; Xie WF
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):638-40. PubMed ID: 14572357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.